UAM_Biblioteca | Unified search engine | Scientific Production Portal | UAM Research Data Repository
Universidad Autónoma de Madrid
Biblos-e Archivo
We are onFacebookCanal BiblosYouTubeTwitterPinterestWhatsappInstagram
    • español
    • English
  • English 
    • español
    • English
  • Log in
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search Biblos-e Archivo

Advanced Search

Browse

All of Biblos-e ArchivoCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsFacultiesThis CollectionBy Issue DateAuthorsTitlesSubjectsFaculties

My Account

Log inRegister

Statistics

View Usage Statistics

Help

Information about Biblos-e ArchivoI want to submit my workI want to submit my doctoral thesisFrequently Asked QuestionsCopyrightsFinancial Agencies and OA policy

UAM_Biblioteca

View Item 
  •   Biblos-e Archivo
  • 1 - Producción científica en acceso abierto de la UAM
  • Producción científica en acceso abierto de la UAM
  • View Item
  •   Biblos-e Archivo
  • 1 - Producción científica en acceso abierto de la UAM
  • Producción científica en acceso abierto de la UAM
  • View Item

Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease

Author
Tuñón, José; Cristóbal, Carmen; Tarín, Nieves; Aceña Navarro, Álvarountranslated; González Casaús, María Luisa; Huelmos, Ana Isabel; Alonso, Joaquín Jesus; Lorenzo, Óscar; González-Parra, Emilio; Mahillo, Ignacio; Pello, Ana María; Carda, Rocío; Farré, Jerónimo; Rodriguez Artalejo, Fernando; López Bescós, Lorenzo; Egido, Jesús
Entity
UAM. Departamento de Medicina; UAM. Departamento de Medicina Preventiva y Salud Pública y Microbiología
Publisher
Public Library of Science
Date
2014-04-18
Citation
10.1371/journal.pone.0095402
Plos One 9.4 (2014): e95402
 
 
 
ISSN
1932-6203 (online)
DOI
10.1371/journal.pone.0095402
Funded by
This work was supported by grants from the following: Fondo de Investigaciones Sanitarias (PI05/0451, PI05/1497, PI05/52475, PI05/1043, PS09/01405, and PI10/00072): http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-financiacion/convocatorias-ayudas-accion-estrategica-salud.shtml; Spanish Society of Cardiology; Spanish Heart Foundation. http://www.secardiologia.es/; Spanish Society of Arteriosclerosis. www.searteriosclerosis.org; RECAVA (RD06/0014/0035); www.recava.com; Fundación Lilly. https://www.lilly.es/nuestra-compania/fundacion-lilly-folder; Instituto de Salud Carlos III FEDER (FJD biobank: RD09/0076/00101); http://www.isciii.es/; and AbbVie Laboratories. http://www.abbvie.es/
Subjects
Biological Markers; Coronary Artery Disease; Fibroblast Growth Factors; Follow-Up Studies; Vitamin D; Prognosis; Medicina
URI
http://hdl.handle.net/10486/667012
Rights
© 2014 Tuñón et al.

Licencia Creative Commons
Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional.

Abstract

Objective: Vitamin D and fibroblast growth factor-23 (FGF-23) are related with cardiovascular disorders. We have investigated the relationship of calcidiol (vitamin D metabolite) and FGF-23 plasma levels with the incidence of adverse outcomes in patients with coronary artery disease. Methods: Prospective follow-up study of 704 outpatients, attending the departments of Cardiology of four hospitals in Spain, 6-12 months after an acute coronary event. Baseline calcidiol, FGF-23, parathormone, and phosphate plasma levels were assessed. The outcome was the development of acute ischemic events (any acute coronary syndrome, stroke, or transient ischemic attack), heart failure, or death. Cox regression adjusted for the main confounders was performed. Results: Calcidiol levels showed a moderate-severe decrease in 57.3% of cases. Parathormone, FGF-23, and phosphate levels were increased in 30.0%, 11.5% and 0.9% of patients, respectively. Only 22.4% of patients had glomerular filtration rate< 60 ml/min1.73 m2. After a mean follow-up was 2.15±0.99 years, 77 patients developed the outcome. Calcidiol (hazard ratio [HR] = 0.67; 95% confidence interval [CI] = 0.48-0.94; p = 0.021) and FGF-23 (HR = 1.13; 95% CI = 1.04-1.23; p = 0.005) plasma levels predicted independently the outcome. There was a significant interaction between calcidiol and FGF-23 levels (p = 0.025). When the population was divided according to FGF-23 levels, calcidiol still predicted the outcome independently in patients with FGF-23 levels higher than the median (HR = 0.50; 95% CI = 0.31-0.80; p = 0.003) but not in those with FGF-23 levels below this value (HR = 1.03; 95% CI = 0.62-1.71; p = 0.904). Conclusions: Abnormalities in mineral metabolism are frequent in patients with stable coronary artery disease. In this population, low calcidiol plasma levels predict an adverse prognosis in the presence of high FGF-23 levels
Show full item record

Files in this item

Thumbnail
Name
coexistence_tunon_PO_2014.pdf
Size
555.3Kb
Format
PDF

Refworks Export

Delicious Save this on Delicious

Google™ Scholar:Tuñón, José - Cristóbal, Carmen - Tarín, Nieves - Aceña Navarro, Álvaro - González Casaús, María Luisa - Huelmos, Ana Isabel - Alonso, Joaquín Jesus - Lorenzo, Óscar - González-Parra, Emilio - Mahillo, Ignacio - Pello, Ana María - Carda, Rocío - Farré, Jerónimo - Rodriguez Artalejo, Fernando - López Bescós, Lorenzo - Egido, Jesús

This item appears in the following Collection(s)

  • Producción científica en acceso abierto de la UAM [14764]

Related items

Showing items related by title, author, creator and subject.

  • Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate 

    González-Parra, Emilio; Aceña Navarro, ÁlvaroAutoridad UAM; Lorenzo, Óscar; Tarín, Nieves; González-Casaus, María Luisa; Cristóbal, Carmen; Huelmos, Ana; Mahillo, Ignacio; Pello, Ana María; Carda, Rocío; Hernández-González, Ignacio; Alonso, Joaquín; Rodríguez-Artalejo, Fernando; López-Bescós, Lorenzo; Ortiz, Alberto; Egido, Jesús; Tuñón, José
    2015-08-23
  • Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale instable coronary disease 

    Higueras, Javier; Martín-Ventura, José Luis; Blanco-Colio, Luis; Cristóbal, Carmen; Tarín, Nieves; Huelmos, Ana; Alonso, Joaquín; Pello, Ana María; Aceña Navarro, ÁlvaroAutoridad UAM; Carda, Rocío; Lorenzo, Óscar; Mahillo, Ignacio; Asensio, Dolores; Almeida, Pedro; Rodríguez-Artalejo, Fernando; Farré, Jerónimo; López Bescós, Lorenzo; Egido, Jesús; Tuñón, José
    2015-03-01
  • Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors 

    Pello, Ana María; Cristóbal, Carmen; Tarín, Nieves; Huelmos, Ana; Aceña Navarro, ÁlvaroAutoridad UAM; Carda, Rocío; González-Casaus, María Luisa; Alonso, Joaquín; Lorenzo, Óscar; Blanco-Colio, Luis; Martín-Ventura, José Luis; Franco Peláez, Juan Antonio; Mahillo, Ignacio; Farré, Jerónimo; López-Bescós, Lorenzo; Egido, Jesús; Tuñón, José
    2016-01-01
All the documents from Biblos-e Archivo are protected by copyrights. Some rights reserved.
Universidad Autónoma de Madrid. Biblioteca
Contact Us | Send Feedback
We are onFacebookCanal BiblosYouTubeTwitterPinterestWhatsappInstagram
 

 

All the documents from Biblos-e Archivo are protected by copyrights. Some rights reserved.
Universidad Autónoma de Madrid. Biblioteca
Contact Us | Send Feedback
We are onFacebookCanal BiblosYouTubeTwitterPinterestWhatsappInstagram